This prospective validation study with a large sample size confirms that the diagnostic yield of NGAL in the context of PAA is only moderate, and therefore, it should not be used as a unique diagnostic tool. The gene discussed is LCN2; the disease is pulmonary artery-aorta diameter ratio measurement.